Markets:

Overview

News

Currencies

International

Treasuries

Compugen Ltd. - Ordinary Shares (NQ:CGEN)

1.640 -0.010 (-0.61%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Compugen Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 Next >

Compugen Ltd (CGEN) Q3 2021 Earnings Call Transcript ↗

November 12, 2021

CGEN earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

48 Stocks Moving In Friday's Mid-Day Session ↗

November 12, 2021

Gainers Everspin Technologies, Inc. (NASDAQ: MRAM) shares climbed 41% to $9.28 after the company reported better-than-expected Q3results and issued Q4 sales guidance above...

Via Benzinga

The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares ↗

November 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded...

Via Benzinga

Earnings Scheduled For November 12, 2021 ↗

November 12, 2021

Companies Reporting Before The Bell • Zevia (NYSE:ZVIA) is estimated to report quarterly loss at $0.43 per share on revenue of $34.40 million. • Natura &Co...

Via Benzinga

Why Compugen Surged 14% Higher on Thursday ↗

November 11, 2021

The company is deepening its partnership with Bristol Myers Squibb.

Via The Motley Fool

91 Biggest Movers From Yesterday ↗

November 12, 2021

Gainers NuZee, Inc. (NASDAQ: NUZE) shares jumped 164.5% to settle at $5.29 on Thursday. NuZee manufacturing partner, Cuvee Coffee, reported an expansion into select Walmart...

Via Benzinga

The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts ↗

November 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Commences Late-Stage Study Of Heart Failure Treatment Merck &...

Via Benzinga

Thursday Market Overview ↗

November 04, 2021

If you are an IBM shareholder you now own something new Kyndryl.

Via Talk Markets

Election Day ↗

November 02, 2021

Teva rose a whopping 8.34% today.

Via Talk Markets

Thursday Market Coverage ↗

October 21, 2021

US jobless benefit applicants last week hit a pandemic low of 290,000, below the estimate of 300,000.

Via Talk Markets

The Secret To Successful Investing In Biotech ↗

October 19, 2021

Have you ever had a stock jump 30%, 50% or 100% in one day?

Via Talk Markets

Chinese Growth Level ↗

October 18, 2021

The hot news today was a much weaker Chinese growth level this year, of 4.9% because of supply chain issues.

Via Talk Markets

More Chinese Trouble ↗

October 14, 2021

A day after the consumer price rise there was another price rise for producer markets.

Via Talk Markets

Markets Boosted ↗

October 07, 2021

Good news helped stock prices.

Via Talk Markets

October Starts Positive ↗

October 01, 2021

A lot of these moves are simply reactions to last month's excesses and they may not be predictive for October at all.

Via Talk Markets

Delta Variant Fears Continue ↗

September 09, 2021

The jobless level fell to 310,000 whereas the consensus forecast was for 335,000, so risks of inflation are higher.

Via Talk Markets

Compugen's Out-Licensed Lung Cancer Candidate Enters Human Trial ↗

August 19, 2021

AstraZeneca Plc's (NASDAQ: AZN) bispecific antibody derived from Compugen Ltd's (NASDAQ: CGEN) COM902 will advance into clinical development. ...

Via Benzinga

Delta Outbreak ↗

August 04, 2021

The US market was droopy because of poor private sector jobless numbers.

Via Talk Markets

Know When To Hold 'Em, Know When To Fold 'Em ... ↗

August 02, 2021

A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks.

Via Talk Markets

News Overload ↗

July 29, 2021

Today US markets managed a rally despite misses in both the growth and employment data.

Via Talk Markets

Why Compugen Stock Is Rising Again Today ↗

July 29, 2021

Momentum is carrying over from the company's second-quarter update on Wednesday.

Via The Motley Fool

Full News Day ↗

July 28, 2021

The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier.

Via Talk Markets

Topics Energy

Compugen Ltd (CGEN) Q2 2021 Earnings Call Transcript ↗

July 28, 2021

CGEN earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Why Compugen Stock Is Jumping Today ↗

July 28, 2021

Investors were especially interested in the company's pipeline update.

Via The Motley Fool

Containment Plan ↗

July 23, 2021

Today the US decided to cut China risks.

Via Talk Markets

Delta Defeats Bulls ↗

July 19, 2021

Stocks tended to crash without rhyme or reason.

Via Talk Markets

Weak Week ↗

July 16, 2021

Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism.

Via Talk Markets

Sell Sell Sell ↗

July 06, 2021

Today the inevitable reversal of wild gains overtook Wall Street, echoing what occurred in major foreign markets Monday.

Via Talk Markets

People Needed ↗

July 02, 2021

If qualified people are not looking for work, they will have to be lured to do so with higher wages.

Via Talk Markets

End Of June ↗

June 30, 2021

Canadian Solar fell 4.6% on fears of plans for a China IPO where its panels are made.

Via Talk Markets

Topics Initial Public Offering

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Compugen Ltd. - Ordinary Shares (NQ:CGEN)

All News about Compugen Ltd. - Ordinary Shares

Starting at $3.75/week.

Subscribe Today